109 related articles for article (PubMed ID: 1316960)
1. Efficacy of continuous zidovudine infusion at early stages of retroviral infection in mice.
Sinet M; Harcouet L; Desforges B; Colin JN; Farinotti R; Pocidalo JJ
J Acquir Immune Defic Syndr (1988); 1992; 5(6):577-82. PubMed ID: 1316960
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing zidovudine efficacy when administered at early stages of Friend virus infection in mice.
Sinet M; Desforges B; Launay O; Colin JN; Pocidalo JJ
Antiviral Res; 1991 Sep; 16(2):163-71. PubMed ID: 1799277
[TBL] [Abstract][Full Text] [Related]
3. Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection.
Morrey JD; Warren RP; Okleberry KM; Burger RA; Johnston MI; Sidwell RW
J Acquir Immune Defic Syndr (1988); 1990; 3(5):500-10. PubMed ID: 2157836
[TBL] [Abstract][Full Text] [Related]
4. Impact of dosing schedule upon suppression of a retrovirus in a murine model of AIDS encephalopathy.
Bilello JA; Eiseman JL; Standiford HC; Drusano GL
Antimicrob Agents Chemother; 1994 Mar; 38(3):628-31. PubMed ID: 8203866
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
Kitagawa M; Kamisaku H; Aizawa S; Sado T
Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of FK-565 alone and in combination with zidovudine on retroviral infection by Friend leukemia virus in mice.
Yokota Y; Wakai Y; Watanabe Y; Mine Y
J Antibiot (Tokyo); 1988 Oct; 41(10):1479-87. PubMed ID: 3192497
[TBL] [Abstract][Full Text] [Related]
7. Early-initiated zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice.
Morrey JD; Okleberry KM; Sidwell RW
J Acquir Immune Defic Syndr (1988); 1991; 4(5):506-12. PubMed ID: 2016687
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of high-dose zidovudine administered as a continuous infusion in patients with cancer.
Marchbanks K; Dudley MN; Posner MR; Darnowski J
Pharmacotherapy; 1995; 15(4):451-7. PubMed ID: 7479197
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex.
Lu L; Shen RN; Zhou SZ; Srivastava C; Harrington M; Miyazawa K; Wu B; Lin ZH; Ruscetti S; Broxmeyer HE
Int J Hematol; 1991 Apr; 54(2):117-24. PubMed ID: 1660735
[TBL] [Abstract][Full Text] [Related]
10. Alteration of cytokine levels in murine retrovirus infection: modulation by combination therapy.
Bowden R; Tate SM; Soto S; Specter S
Int J Immunopharmacol; 1999 Dec; 21(12):815-27. PubMed ID: 10606002
[TBL] [Abstract][Full Text] [Related]
11. Development of a real-time quantitative reverse transcriptase PCR assay for detection of the Friend leukemia virus load in murine plasma.
He JY; Cheng HJ; Wang YF; Zhu YT; Li GQ
J Virol Methods; 2008 Feb; 147(2):345-50. PubMed ID: 18068233
[TBL] [Abstract][Full Text] [Related]
12. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
13. Murine models for antiretroviral therapy.
Ruprecht RM
Intervirology; 1989; 30 Suppl 1():2-11. PubMed ID: 2540110
[TBL] [Abstract][Full Text] [Related]
14. Molecular assessment of the potential combination therapy of cytokines with biphalin and AZT for Friend leukemia virus infection in vitro.
Tang JL; Lipkowski AW; Specter S
Pharmacol Rep; 2008; 60(2):190-8. PubMed ID: 18443380
[TBL] [Abstract][Full Text] [Related]
15. Modulation of ex vivo cytokine production by splenocytes using in vitro combined therapeutics in murine retroviral model.
Kang LC; Kerben MJ; Ugen KE; Specter SC
DNA Cell Biol; 1999 Jul; 18(7):585-92. PubMed ID: 10433557
[TBL] [Abstract][Full Text] [Related]
16. Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients.
Morse GD; Portmore AC; Marder V; Plank C; Olson J; Taylor C; Bonnez W; Reichman RC
Antimicrob Agents Chemother; 1992 Oct; 36(10):2245-52. PubMed ID: 1444306
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effect of D-aspartic acid beta-hydroxamate (DAH) on Friend virus-infected erythropoietic progenitor cells.
Tournaire R; Arnaud S; Hamedi-Sangsari F; Malley S; Grange J; Blanchet JP; Doré JF; Vila J
Leukemia; 1994 Oct; 8(10):1703-7. PubMed ID: 7934166
[TBL] [Abstract][Full Text] [Related]
18. Impeded progression of Friend disease in mice by an inhibitor of retroviral proteases.
Lai MH; Tang J; Wroblewski V; Dee AG; Margolin N; Vlahos C; Bowdon B; Buckheit R; Colacino J; Hui KY
J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):24-31. PubMed ID: 8093263
[TBL] [Abstract][Full Text] [Related]
19. Implications of the kinetics of zidovudine in the pregnant baboon following oral administration.
Garland M; Szeto HH; Daniel SS; Tropper PJ; Myers MM; Stark RI
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):433-40. PubMed ID: 9859956
[TBL] [Abstract][Full Text] [Related]
20. The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites.
Barry MG; Khoo SH; Veal GJ; Hoggard PG; Gibbons SE; Wilkins EG; Williams O; Breckenridge AM; Back DJ
AIDS; 1996 Oct; 10(12):1361-7. PubMed ID: 8902065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
